Treatment With Anakinra, a Recombinant IL‐1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. (June 2015) - Hahn, Katherine J; Ho, Nancy; Yockey, Lynne; Kreuzberg, Samantha; Daub, Janine; Rump, Amy; Marciano, Beatriz E; Quezado, Martha; Malech, Harry L; Holland, Steven M; Heller, Theo; Zerbe, Christa S